MedTrace Logo

Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)

NCT00452829 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-06-24

No results posted yet for this study

Summary

The aim of the study is to develop a randomised, double blind clinical trial to compare (i) folic acid plus inositol, with (ii) folic acid plus placebo, for prevention of recurrent neural tube defects.

Conditions

  • Recurrent Neural Tube Defects

Interventions

DRUG

Folic Acid and inositol

Folic Acid and inositol

DRUG

Folic acid and placebo

Folic acid and placebo

Sponsors & Collaborators

  • Institute of Child Health

    lead OTHER

Principal Investigators

  • Andrew Copp, Prof · Institute Of Child Health and Great Ormond Street Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00452829 on ClinicalTrials.gov